Elutia (ELUT) to Release Quarterly Earnings on Wednesday

Elutia (NASDAQ:ELUT) will be announcing its earnings results after the market closes on Wednesday, August 7th. Investors that wish to register for the company’s conference call can do so using this link.

Elutia (NASDAQ:ELUT) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.75) earnings per share (EPS) for the quarter. The business had revenue of $6.69 million during the quarter.

Elutia Price Performance

Shares of Elutia stock traded up $0.25 during trading hours on Tuesday, hitting $2.98. The company’s stock had a trading volume of 22,074 shares, compared to its average volume of 42,956. Elutia has a 12 month low of $1.10 and a 12 month high of $5.24. The stock has a 50 day moving average of $3.83 and a 200 day moving average of $3.50. The company has a market capitalization of $72.32 million, a PE ratio of -1.27 and a beta of 0.72.

Analyst Upgrades and Downgrades

ELUT has been the subject of several recent research reports. Lake Street Capital upped their price objective on Elutia from $5.00 to $10.00 and gave the stock a “buy” rating in a research report on Friday, June 21st. Cantor Fitzgerald increased their target price on Elutia from $5.00 to $11.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 18th.

About Elutia

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.